Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheli Melzer Cohen

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Journal of Clinical Medicine|February 11, 2023
Real-World Use of Alirocumab: Experience from a Large Healthcare ProviderAvishay Elis, Cheli Melzer Cohen, Gabriel Chodick
Journal of Diabetes|April 19, 2017
Effectiveness of vildagliptin as add-on to metformin monotherapy among uncontrolled type 2 diabetes mellitus patients in a real-world settingCheli Melzer Cohen, Carla Davis, Varda Shalev, et al.
Endocrinology, Diabetes & Metabolism|July 25, 2020
The effectiveness of insulin glargine 300 U/mL among type 2 diabetes patients: Analysis of a real-world data in IsraelCheli Melzer Cohen, Tamar Banon, Varda Shalev, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 7, 2019
Metabolic Control and Adherence to Therapy in Type 2 Diabetes Mellitus Patients Using IDegLira in a Real-World SettingCheli Melzer-Cohen, Gabriel Chodick, Shiran Naftelberg, et al.
Journal of Biomedical Informatics|September 13, 2022
Temporal patterns selection for All-Cause Mortality prediction in T2D with ANNsPavel Novitski, Cheli Melzer Cohen, Avraham Karasik, et al.
Diabetes, Obesity & Metabolism|September 13, 2018
Acute renal outcomes with sodium-glucose co-transporter-2 inhibitors: Real-world data analysisAvivit Cahn, Cheli Melzer-Cohen, Rena Pollack, et al.
Diabetes Research and Clinical Practice|March 9, 2025
Drug adherence, glycemic control, and weight reduction with subcutaneous semaglutide in real-world management of type 2 diabetesCheli Melzer Cohen, Ofri Mosenzon, Alona Aharonovich, et al.
Value in Health Regional Issues|August 18, 2020
Elevated Costs and Healthcare Resource Utilization in Patients With Type 2 Diabetes and Established Cardiovascular Disease in IsraelCheli Melzer Cohen, Nino Hallén, Gabriel Chodick, et al.
Pharmacoeconomics - Open|April 27, 2021
Short-Term Excess Healthcare Costs Associated with Cardiovascular Events Among Adults with Type 2 Diabetes in Israel: A Retrospective Cohort StudyCheli Melzer Cohen, Nino Hallén, Gabriel Chodick, et al.
Medicine|February 1, 2019
Anxiolytic treatment but not anxiety itself causes hyponatremia among anxious patientsMayan Gilboa, Gideon Koren, Racheli Katz, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Journal of Clinical Medicine|February 11, 2023
Real-World Use of Alirocumab: Experience from a Large Healthcare ProviderAvishay Elis, Cheli Melzer Cohen, Gabriel Chodick
Journal of Diabetes|April 19, 2017
Effectiveness of vildagliptin as add-on to metformin monotherapy among uncontrolled type 2 diabetes mellitus patients in a real-world settingCheli Melzer Cohen, Carla Davis, Varda Shalev, et al.
Endocrinology, Diabetes & Metabolism|July 25, 2020
The effectiveness of insulin glargine 300 U/mL among type 2 diabetes patients: Analysis of a real-world data in IsraelCheli Melzer Cohen, Tamar Banon, Varda Shalev, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 7, 2019
Metabolic Control and Adherence to Therapy in Type 2 Diabetes Mellitus Patients Using IDegLira in a Real-World SettingCheli Melzer-Cohen, Gabriel Chodick, Shiran Naftelberg, et al.
Journal of Biomedical Informatics|September 13, 2022
Temporal patterns selection for All-Cause Mortality prediction in T2D with ANNsPavel Novitski, Cheli Melzer Cohen, Avraham Karasik, et al.
Diabetes, Obesity & Metabolism|September 13, 2018
Acute renal outcomes with sodium-glucose co-transporter-2 inhibitors: Real-world data analysisAvivit Cahn, Cheli Melzer-Cohen, Rena Pollack, et al.
Diabetes Research and Clinical Practice|March 9, 2025
Drug adherence, glycemic control, and weight reduction with subcutaneous semaglutide in real-world management of type 2 diabetesCheli Melzer Cohen, Ofri Mosenzon, Alona Aharonovich, et al.
Value in Health Regional Issues|August 18, 2020
Elevated Costs and Healthcare Resource Utilization in Patients With Type 2 Diabetes and Established Cardiovascular Disease in IsraelCheli Melzer Cohen, Nino Hallén, Gabriel Chodick, et al.
Pharmacoeconomics - Open|April 27, 2021
Short-Term Excess Healthcare Costs Associated with Cardiovascular Events Among Adults with Type 2 Diabetes in Israel: A Retrospective Cohort StudyCheli Melzer Cohen, Nino Hallén, Gabriel Chodick, et al.
Medicine|February 1, 2019
Anxiolytic treatment but not anxiety itself causes hyponatremia among anxious patientsMayan Gilboa, Gideon Koren, Racheli Katz, et al.
Pageof 4